Sign In
Buy NVS
$148.93
+1.85 (+1.26%)
At Close: Jun 22, 2026
Behcets Syndrome Market to See Booming Growth 2021-2028 | Novartis AG, AbbVie Inc., and Celgene Corporation among others.
06:48am, Monday, 22'nd Nov 2021 OpenPR
The biopharma industry has high ambitions to improve therapies for patients across many disease categories, drawing on a wealth of technological advances that have been emerging and maturing in recent years. Even after the mass mobilization against COVID-19, it is
Rickets Treatment Market Cost Analysis, Strategy and Growth Factor Report 2028 | Novartis AG, Merck KGaA, and Pfizer Inc
06:46am, Monday, 22'nd Nov 2021 OpenPR
Global Rickets Treatment Market: Snapshot The demand opportunities in the rickets treatment market have been rising in the upcoming years. This growth is on the back of technological advancements in the field of pediatric care. The market presence of stellar industry
The biopharma industry has high ambitions to improve therapies for patients across many disease categories, drawing on a wealth of technological advances that have been emerging and maturing in recent years. Even after the mass mobilization against COVID-19, it is
Lupus Therapeutic Market Strategic Assessment by Key Players: Glaxosmithkline Plc, Aurinia Pharmaceuticals Inc., Novartis AG, F. Hoffmann-La Roche
05:56am, Monday, 22'nd Nov 2021 OpenPR
Lupus Therapeutic Market report considers the latest upgrades while assessing the development of leading market players. This global market report is comprehensive and opens a door of worldwide market for the products. The report gives helpful insights which assist while
Neurological Disorder Drugs Market report considers the latest upgrades while assessing the development of leading market players. This global market report is comprehensive and opens a door of worldwide market for the products. The report gives helpful insights which assist
Trachoma Market will Perceive Robust Expansion by 2027 l Key players: Novartis AG, Pfizer, Inc., Allergan, Teva Pharmaceutical Industries Ltd., Fresenius
05:49am, Monday, 22'nd Nov 2021 OpenPR
Trachoma Market report considers the latest upgrades while assessing the development of leading market players. This global market report is comprehensive and opens a door of worldwide market for the products. The report gives helpful insights which assist while launching
Webster Bank N. A. Trims Stock Holdings in Novartis AG (NYSE:NVS)
04:40pm, Saturday, 20'th Nov 2021 Transcript Daily
Webster Bank N. A. decreased its position in Novartis AG (NYSE:NVS) by 24.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,250 shares of the companys stock after selling 400 shares during the period. Webster Bank N. A.s holdings in Novartis were []
Trust Co. of Toledo NA OH Raises Holdings in Novartis AG (NYSE:NVS)
06:06pm, Friday, 19'th Nov 2021 Transcript Daily
Trust Co. of Toledo NA OH increased its position in Novartis AG (NYSE:NVS) by 9.6% in the 3rd quarter, Holdings Channel reports. The firm owned 24,628 shares of the companys stock after buying an additional 2,154 shares during the period. Trust Co. of Toledo NA OHs holdings in Novartis were worth $2,014,000 as of its []
New filing by NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE
04:08pm, Friday, 19'th Nov 2021 The FEC
The NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE successfully filed their F3XN NOVEMBER MONTHLY with the coverage period of 10/01/2021 to 10/31/2021 and a confirmation ID of FEC-1549179 *********CommitteeId: C00033969 | FilingId: 1549179 | FormType: F3XN | CoverageFrom: 10/01/2021 | CoverageThrough: 10/31/2021 | ReportType: NOVEMBER MONTHLY*********
EQT, Biontech investor family consider Sandoz bid - Handelsblatt
11:16am, Friday, 19'th Nov 2021
Investment group EQT and members of the Struengmann family, who are investors in Biontech, are considering a joint bid for Swiss pharmaceutical group Novartis's generics division Sandoz, German newspa
The Gene and Cell Therapies Targeting CNS Disorders Market report focus on the current trends of the market along with detailed analysis which provides data regarding this market rate, and it also predicts the future market growth rate. The Gene
Aneurysm Treatment Market report considers the latest upgrades while assessing the development of leading market players. This global market report is comprehensive and opens a door of worldwide market for the products. The report gives helpful insights which assist while
Data Bridge Market research released a new market study on Human Papillomavirus Vaccine with 100+ market data Tables, Pie Chart, Graphs & Figures spread through Pages and easy to understand detailed analysis In Human Papillomavirus Vaccine research report also
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
07:23pm, Thursday, 18'th Nov 2021 Benzinga
Full story available on Benzinga.com
Timber Creek Capital Management LLC Boosts Position in Novartis AG (NYSE:NVS)
06:52pm, Thursday, 18'th Nov 2021 Transcript Daily
Timber Creek Capital Management LLC raised its stake in shares of Novartis AG (NYSE:NVS) by 5.1% in the third quarter, Holdings Channel reports. The institutional investor owned 68,519 shares of the companys stock after buying an additional 3,337 shares during the quarter. Novartis comprises about 1.8% of Timber Creek Capital Management LLCs portfolio, making the []
